These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32141854)

  • 1. [PRACTICE OF MANAGEMENT OF PATIENTS WITH INFECTIOUS ENDOCARDITIS IN CONDITIONS OF LOW FREQUENCY OF ETIOLOGICALLY SIGNIFICANT PATHOGENS IN THE RUSSIAN FEDERATION].
    Danilov A; Kozlov S; Zharkova L; Sviridov V; Sviridova Y; Bagaturiya G; Evseev A
    Georgian Med News; 2020 Jan; (298):75-79. PubMed ID: 32141854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special issues in the management of infective endocarditis caused by gram-positive cocci.
    Hoen B
    Infect Dis Clin North Am; 2002 Jun; 16(2):437-52, xi. PubMed ID: 12092481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of daptomycin in infective endocarditis caused by Gram-positive cocci.
    Cervera C; Castañeda X; Pericas JM; Del Río A; de la Maria CG; Mestres C; Falces C; Marco F; Moreno A; Miró JM
    Int J Antimicrob Agents; 2011 Nov; 38(5):365-70. PubMed ID: 21420835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the MIC useful in deciding to treat endocarditis surgically?
    Walton BI; Wallace SM; Kukreja N; Kharbanda R; Varey-Tyburczy E; Wilson AP; Swanton RH
    Int J Antimicrob Agents; 2004 Apr; 23(4):394-7. PubMed ID: 15081090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.
    Falagas ME; Giannopoulou KP; Ntziora F; Vardakas KZ
    J Antimicrob Chemother; 2007 Jul; 60(1):7-19. PubMed ID: 17550889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis.
    Hidalgo-Tenorio C; Gálvez J; Martínez-Marcos FJ; Plata-Ciezar A; De La Torre-Lima J; López-Cortés LE; Noureddine M; Reguera JM; Vinuesa D; García MV; Ojeda G; Luque R; Lomas JM; Lepe JA; de Alarcón A
    BMC Infect Dis; 2020 Feb; 20(1):160. PubMed ID: 32085732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
    Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
    Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Risk Factors for Infective Endocarditis in
    Salvador VB; Chapagain B; Joshi A; Brennessel DJ
    Tex Heart Inst J; 2017 Feb; 44(1):10-15. PubMed ID: 28265207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections.
    Seng P; Amrane S; Million M; Stein A
    Int J Antimicrob Agents; 2017 May; 49(5):558-564. PubMed ID: 28365430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
    Jongsma K; Joson J; Heidari A
    J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
    Nagura J; Kijima K; Kurazono M; Takahata S; Sugano T; Tanaka Y; Hirai Y; Yamada K; Takayama Y; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3526-8. PubMed ID: 16048975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH
    Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of teicoplanin on Staphylococcus aureus with heterointermediate susceptibility to glycopeptides in experimental infective endocarditis model.
    Vas KE; Török Á; Cordoş B; Vancea S; Brassai A; Székely E
    J Chemother; 2016 Oct; 28(5):446-9. PubMed ID: 25976829
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of bacterial etiological agents, sensitivity pattern and clinical outcome of patients with bacterial endocarditis at Punjab Institute of Cardiology, Lahore.
    Fayyaz I; Rasheed MA; Ashraf M; Bukhsh A; Wadood A
    J Pak Med Assoc; 2014 Dec; 64(12):1384-8. PubMed ID: 25842583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antibiotic use in misdiagnosed infective endocarditis-no impact on mortality.
    Krcmery V; Hricak V; Fischer V; Jurco R; Demitrovicova A; Mlkvy P; Karvaj M; Bauer F; Rudinsky B; Kovac M; Kalavsky E; Kisac P; Findova L; Marks P
    Int J Antimicrob Agents; 2007 Dec; 30(6):564-5. PubMed ID: 17900871
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.
    Balkhair A; Al Muharrmi Z; Darwish L; Farhan H; Sallam M
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e227-9. PubMed ID: 20005763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Falagas ME; Matthaiou DK; Bliziotis IA
    J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infective endocarditis caused by Streptococcus agalactiae: time for beta-hemolytic streptococci to follow treatment recommendations for S. aureus?
    Sendi P
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):419-422. PubMed ID: 30680556
    [No Abstract]   [Full Text] [Related]  

  • 19. Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.
    Baxi SM; Chan D; Jain V
    Infection; 2015 Dec; 43(6):751-4. PubMed ID: 25805524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infective endocarditis of staphylococcal etiology: clinical process and antibacterial therapy].
    Iakovlev SV; Shcheka DV; Suvorova MP; Sergeeva EV; Cherkasova NA
    Antibiot Khimioter; 2009; 54(5-6):59-64. PubMed ID: 20052920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.